The data from Wagner et al.32 also originates from different breast cancer types—ER+, PR+, Her2+, and triple-negative: this allows testing if microscopic niches identified in the triple-negative breast tumors of Keren et al.21 generalize across breast cancer types. This evidence concerns the gene ERBB2 and breast cancer.